No Distinct Advantage For Electronic Drug Labeling

Published Online: Tuesday, September 10, 2013
In a recent report, the Government Accountability Office (GAO) did not find a consensus among stakeholders on the potential benefits and harms of eliminating paper drug labeling and relying solely on electronic labeling.

The report, released on July 8, 2013, evaluated the advantages and disadvantages of replacing paper labeling, including prescribing information for health care practitioners, medication guides about drugs the FDA has deemed to be a serious public health concern, and patient package inserts required for oral contraceptives and estrogens, with electronic labeling. In interviews conducted by the GAO, some stakeholders said that electronic labeling would provide physicians, pharmacists, and patients with updated drug information in a user-friendly format.

However, electronic labeling could limit access to drug information, as some individuals may not know how to use, or may not have access to, the Internet. Stakeholders also expressed concern about the quality of information available and the need for 1 reliable, unbiased source of drug information.

A complete shift from paper to electronic labeling would also require changing federal regulations for 2 of the 3 types of drug labeling, shifting some responsibilities from drug manufacturers to pharmacies. Pharmacies would also be responsible for covering printing costs for patients who wanted to continue to receive paper labeling.

Latest Articles
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
Latest Issues